| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-2999(84)90353-4 |
| P698 | PubMed publication ID | 6541140 |
| P2093 | author name string | R F Nutt | |
| R J Winquist | |||
| E P Faison | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 169-173 | |
| P577 | publication date | 1984-06-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Vasodilator profile of synthetic atrial natriuretic factor | |
| P478 | volume | 102 |
| Q42086145 | A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro. |
| Q35756623 | Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP. |
| Q42145315 | Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries |
| Q70023978 | Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia |
| Q37579632 | Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle |
| Q42148631 | Atrial natriuretic factor recognizes two receptor subtypes in endothelial cells cultured from bovine pulmonary artery. |
| Q39177600 | Atrial natriuretic factor: a hormone secreted by the heart |
| Q70013325 | Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors |
| Q41133442 | Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen |
| Q69876291 | Atrial natriuretic peptide in Bartter's syndrome |
| Q44215518 | Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats |
| Q50517230 | Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension. |
| Q67464838 | Atrial natriuretic peptide suppresses renal vasoconstriction induced by angiotensin II and norepinephrine in dogs |
| Q36777834 | Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics |
| Q39165774 | Atrial natriuretic peptides: clues to their physiological and clinical importance |
| Q70016992 | Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow |
| Q41353586 | Atrial pressure and secretion of atrial natriuretic factor into the human central circulation |
| Q69995185 | Atrial receptors, natriuretic peptides, and the kidney--current understanding |
| Q36398558 | Atrial regulation of intravascular volume: Observations on the tachycardia-polyuria syndrome |
| Q43703935 | Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. |
| Q57791732 | Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis |
| Q41953315 | Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole |
| Q68419812 | Different effects of alpha-human atrial natriuretic peptide and nitroglycerin on cardiac dimensions in humans |
| Q41153812 | Effect of atrial natriuretic peptide and on atriopeptins on the human isolated bronchus. Comparison with the reactivity of the guinea-pig isolated trachea |
| Q50899317 | Effects of atrial natriuretic polypeptide and organic nitrates on levels of relaxation and cyclic nucleotide of canine coronary artery with and without endothelial injury. |
| Q40624466 | Effects of cyclic GMP on smooth muscle relaxation. |
| Q33683177 | Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells |
| Q70038239 | Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension |
| Q69312177 | Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man |
| Q52222507 | In situ hybridization of atrial natriuretic peptide mRNA in the endothelial cells of human umbilical vessels. |
| Q46956217 | Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig. |
| Q37135306 | Interactions between atrial natriuretic factor and the autonomic nervous system. |
| Q35576160 | Measurement of cytoplasmic free Ca2+ concentration in rabbit aorta using the photoprotein, aequorin. Effect of atrial natriuretic peptide on agonist-induced Ca2+ signal generation |
| Q48687160 | Origin of porcine brain natriuretic peptide-like immunoreactive innervation of the middle cerebral artery in the rat |
| Q69874848 | Plasma atrial natriuretic factor in congestive heart failure |
| Q69865288 | Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers |
| Q71817690 | Platelet aggregation and atrial natriuretic peptide |
| Q39141080 | Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth |
| Q70045053 | Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis |
| Q39195631 | Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles |
| Q39479947 | The atrial natriuretic factor |
| Q47430911 | The bovine endothelin receptor has an apparent molecular weight of 43 000 |
| Q41969059 | The mechanism of relaxation induced by atrial natriuretic peptide in the porcine renal artery |
| Q39472273 | Vascular actions of atrial natriuretic peptide |
| Q43229256 | Vascular responses to local atrial natriuretic peptide infusion in man. |
| Q35579032 | Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. |
| Q37406972 | Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line |
Search more.